Exhaustive analysis about juvenile idiopathic arthritis by using an anti-IL-6 receptor antibody
Exhaustive analysis about juvenile idiopathic arthritis by using an anti-IL-6 receptor antibody
批准号:
16390305
负责人:
YOKOTA Shumpei
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We analyzed the identification of the target molecule of the IL-6 obstruction treatment by using proteomics method such as 2D-DIGE (fluorescent labeling 2 dimension differential gel electrophoresis) and iTRAQ (Isotope Tag for Relative and Absolute Quantitation) method. Additionally, we examined the role of IL-6 on Kawasaki disease or CINCA syndrome as an axis of this research.Furthermore, we would like to analyze the IL-6 diseases (cytokine-related disease) in pediatric field, and to examine the structure and/or the function of the obstruction target molecule of antiIL-6 receptor antibody treatment front and back in detail in future. Finally, in this study, we detected lots of proteins in sera and plasma of JIA patients using two methods, 2D-DIGE and iTRAQ and could identify some of them.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
期刊:
JAMA (under construction)
影响因子:
--
作者:
[Yokota S, Mori M]
通讯作者:
Mori M
Proposal for Juvenile Idiopathic Arthritis Guidance on Diagnosis and Treatment in Primary Care (2007)
青少年特发性关节炎初级保健诊断和治疗指南提案(2007 年)
DOI:
--
发表时间:
期刊:
Modern Rheumatology (in print)
影响因子:
--
作者:
[Yokota S, Mori M.]
通讯作者:
Mori M.
Therapeutic Efficacy of Humanized Recombinant Anti-IL 6-receptor Antibody in Children with Systemic-onset Juvenile Idiopathic Arthritis.
人源化重组抗 IL 6 受体抗体对全身性幼年特发性关节炎儿童的治疗效果。
DOI:
--
发表时间:
2005
期刊:
Arthritis Rheum 52
影响因子:
--
作者:
[Shumpei Yokota, Takako Miyamae, Iwata N, Katakura S, Mori M, Woo P, Nishimoto N, Yoshizaki K, Kishimoto T.]
通讯作者:
Kishimoto T.
Tocilizumab, Anti-IL-6 Receptor Monoclonal Antibody : Randomized, Double-blind, Placebo-controlled, Withdrawal Phase III Trial of Efficacy and Safety against Systemic-onset Juvenile Idiopathic Arthritis
托珠单抗,抗 IL-6 受体单克隆抗体:针对全身性幼年特发性关节炎的有效性和安全性的随机、双盲、安慰剂对照、停药 III 期试验
DOI:
--
发表时间:
期刊:
NEJM (in print)
影响因子:
--
作者:
[Yokota S, Imagawa T.]
通讯作者:
Imagawa T.
Analysis and therapeutic research for growth impairment accompanied with chronic inflammatory syndrome of children as dysregulation of proinflammatory cytokines
-
批准号:23591546
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:YOKOTA Shumpei
-
依托单位:
TLR/Nod proteins in infants from dysregulation Pathological analysis Cytokine Storm
-
批准号:19390287
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.23万
-
财政年份:2007
-
负责人:YOKOTA Shumpei
-
依托单位:
Elucidation of pathogenesis of influenza-related encephalopathy using functional failure in rat glia cells
-
批准号:14370249
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.62万
-
财政年份:2002
-
负责人:YOKOTA Shumpei
-
依托单位:
PATHOPHYSIOLOGY OF INTRACRANIAL CYTOKINES IN INFLUENZA-ASSOCIATED ENCEPHALOPATHY
-
批准号:12470169
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.9万
-
财政年份:2000
-
负责人:YOKOTA Shumpei
-
依托单位:
MACROPHAGE ACTIVATION SYNDROME -ANALYSIS OF CLINICOPHYSIOLOGY AND ESTABLISHMENT OF THERAPY.
-
批准号:08670903
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:YOKOTA Shumpei
-
依托单位:
DISEASE-ACTIVITY MARKERS IN EPSTEIN-BARR VIRUS INFECTION AND ESTABLISHMENT OF CELL-LINE POSITIVE FOR EB VIRUS.
-
批准号:06670814
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1994
-
负责人:YOKOTA Shumpei
-
依托单位:
Analysis of 1pr-dnT Cell Function in Sle-Prone Mouse, MRL/1pr.
-
批准号:63570449
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1988
-
负责人:YOKOTA Shumpei
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
七氟烷通过调控IL-6/FSP1轴抑制心肌铁死亡减轻心肌缺血再灌注损伤的机制研究
-
批准号:JCZRLH202601296
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
盐酸小檗碱抑制NF-κB/IL-6/STAT3信号通路重塑免疫微环境并增敏肺癌免疫治疗的研究
-
批准号:JCZRLH202600985
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
-
批准号:JCZRLH202601410
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于"热证可灸"理论的中药联合铺棉灸治疗带状疱疹急性期的临床疗效及对血清SP、β-EP、IL-6、IL-10、NSE水平的影响
-
批准号:2026JJ81075
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄迎春
-
依托单位:
基于“截断扭转”学说探讨凉膈散通过IL-6/STAT3/RORγt轴调控脓毒症Th17/Treg稳态的机制及临床研究
-
批准号:2026JJ82600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄磊
-
依托单位:
基于IL-6/STAT3通路巨噬细胞极化调控免疫反应在胸膜结核瘤形成中的机制
-
批准号:2026JJ82516
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张锋
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肺上皮细胞SHIP1通过IL-6/GLS1轴调控成纤维细胞脯氨酸代谢重编程在肺纤维化中的机制研究
-
批准号:JCZRQNB202600510
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: